Medicine@Yale publication

Medicine@Yale.

July/August 2006  Volume 2 Issue 4

Inside this issue

Cover stories

A love of Yale, a vision for its future

A faster pipeline speeds new treatments from lab to patient

“Teacher’s teacher” to oversee curriculum as education dean

Partnerships

Biology, medicine unite in new grad initiative

Grants & contracts

People

Pioneer of antiviral therapies is awarded the Parker Medal, school’s highest honor

Expert on autism is named new director of Child Study Center

Blood cell researcher is named new chair of Laboratory Medicine

Yale biochemist is elected to the world’s oldest scientific society

Lifelines: Rebel with a cause

Out & about

Awards & honors

Education

Superb teaching is rewarded at graduation

Science

New protein chips are a window on the womb

An eye for science

Advances: Trading life and limb in pursuit of being thin | How immunity is MIFfed by malaria | Placenta may hold autism's earliest mark| Curbing the scourge of deadly diarrhea



image pdf icon

Download this whole issue as a PDF file

Grants and contracts awarded to Yale School of Medicine, January/February 2006

Federal

  • Meenakshi Alreja, NIH, Cholinergic and GABAergic Mechanisms in the Septohippocampal Pathway, 5 years, $1,545,940
  • Peter Cresswell, NIH, Role of Endocytosis in Cell Recognition, 5 years, $2,043,750
  • Sankar Ghosh, NIH, Mechanism of T Cell-Receptor Mediated Activation of NFκB, 5 years, $2,043,750
  • Tibor Hajszan, NIH, Antidepressant Effect on Hippocampal Synaptogenesis, 3 years, $850,966
  • Nathan Hansen, NIH, Intervention for HIV+ Adults With Childhood Sexual Abuse, 4 years, $899,966
  • Ralph Hoffman, NIH, rTMS Clinical Trial for Auditory Hallucinations, 5 years, $2,135,810
  • Akiko Iwasaki, NIH, Viral Recognition by Plasmacytoid Dendritic Cell, 4 years, $2,043,750
  • Jeffrey Kahn, NIH, The Role of a Novel Coronavirus in Kawasaki Disease, 2 years, $437,795
  • Robert LaMotte, NIH, Satellite Glia and Sensory Coding: Implications for Pain, 1 year, $404,663
  • Peter Novick, NIH, Structure and Inheritance of the Endoplasmic Reticulum, 3 years, $1,209,900
  • Jordan Pober, NIH, Alloimmunity to Progenitor Cell-Derived Human Vascular Cells, 4 years, $2,993,312
  • Pasko Rakic, NIH, Apoptosis and Renewal of Neural Progenitor Cells, 5 years, $1,636,221
  • David Rimm, NIH, Predicting Metastasis in Melanoma, 3 years, $1,044,764
  • Scott Rivkees, NIH, Anti-Adenosine Therapy of Neonatal Brain Injury, 1 year, $183,938
  • Craig Roy, NIH, Evasion of Antigen Presentation by Vacuolar Pathogens, 5 years, $2,043,750; NIH, Modulation of Host Cell Functions by Coxiella burnetii, 4 years, $1,839,375
  • Kerry Russell, NIH, Cardiovascular Effects of Endothelial-Derived Neuregulin, 4 years, $2,037,464
  • Mark Shlomchik, NIH, Differential GVHD Induction by Naive and Memory T Cells, 4 years, $1,635,000
  • Mark Solomon, NIH, Anaphase Promoting Complex-Mediated Proteolysis, 3 years, $1,406,100
  • Stephen Strittmatter, NIH, Nogo Receptor Antagonist for Ischemic Stroke Recovery, 5 years, $1,430,625
  • Scott Strobel, NIH, Mechanism of Ribosome-Catalyzed Peptide Bond Formation, 3 years, $1,322,074
  • Joann Sweasy, NIH, DNA Polymerase Β and Colon Cancer, 2 years, $341,715

Non-Federal

  • Serap Aksoy, Ambrose Monell Foundation, New Strategies for African Trypanosomiasis Control, 1 year, $100,000
  • Jeffrey Bender, Pfizer, Inc., Atorvastatin’s Impact on Vascular Wall Inflammation by Interfering with Isoprehylation and RAC-1 Function, 16 months, $64,690
  • Elizabeth Bradley, William J. Clinton Foundation, Ethiopia Hospital Management Initiative, 1 year, $604,610
  • Margaret Briggs-Gowan, University of Illinois, Chicago, Observational Measurement of Preschool Behavior Problems, 7 months, $18,842
  • Susan Busch, Robert Wood Johnson Foundation, The Effect of State Parity Laws on Children, 1 year, $64,872
  • Jan Czyzyk, American Cancer Society, Inc., Alternative Effectors of Ras GTPase in T Cell Activation, 4 years, $720,000
  • Maria Diuk-Wasser, G. Harold and Leila Y. Mathers Charitable Foundation, Development of an Interactive Internet Site for Lyme Disease Education, 1 year, $51,425
  • Barbara Ehrlich, PKD Foundation for Research in Polycystic Kidney Disease, Molecular Coupling Between the InsP3 Receptor and Polycystin 2: InsP3 Receptor Isoform Specificity for Cyst Formation, 1 year, $65,000
  • Gerald Friedland, Doris Duke Charitable Foundation, Supplement Provision of HIV Care, Antiretroviral Therapy and Prevention Through a Community-Based Program in Rural South Africa, 1 year, $25,000
  • Alan Garen, Breast Cancer Alliance, Inc., Breast Cancer Immunotherapy Using Targeted Nanoparticles Encoding an Icon, 1 year, $100,000
  • Walter Gilliam, Community Foundation for Greater New Haven, Mother Read/Father Read Evaluation, 1 year, $87,000
  • Nora Groce, International Labor Organization, The Impact of HIV/AIDS on Disabled Populations: Policy Interventions, 5 months, $30,000
  • Handan Gunduz-Bruce, National Alliance for Research on Schizophrenia and Depression, GABA-Glutamate Interactions and Psychosis, 2 years, $60,000
  • Melinda Irwin, Fred Hutchinson Cancer Research Center, TREC Coordination Center, 1 year, $22,346
  • Kathleen Koenig, Organization for Autism Research, Development of an Instrument for Measuring Change in Social Behavior in Children with Autism Spectrum Conditions: The Social Behavior Observation Measure, 2 years, $29,784
  • James Leckman, New York Medical College, Role of Group A Streptococcal Infection and HLA Type in TS and OCD, 1 year, $8,548
  • Guoyong Li, American Heart Association, Characterization of a Novel Monoamine Oxidase, Renalase, 3 years, $260,000
  • Xingguang Luo, Alcoholic Beverage Medical Research Foundation, Fine-Mapping Risk Alleles for Alcohol Dependence at the CHRM2 Locus, 1 year, $50,000
  • Linda Mayes, Patrick & Catherine Weldon Donaghue Medical Research Foundation, Minding the Baby: Home Visiting for Young Parents, 3 years, $79,636
  • Guillermo Mor, Laboratory Corporation of America Holdings, Ovarian Cancer Support, 3 years, $150,000; Novogen Limited, Assay of Induction of Apoptosis by Phenoxodiol in Cancer Cells, 1 year, $89,920
  • Utpal Pal, American Heart Association, Molecular Pathogenesis of Lyme Carditis, 6 months, $260,000
  • A. David Paltiel, Massachusetts General Hospital, Optimizing HIV Care in Less-Developed Countries, 3 years, $14,668
  • Reuven Rabinovici, Cellphire, Inc, The Efficacy of Freeze-Dried Platelets in a Rat Model of Uncontrolled Hemorrhagic Shock, 1 year, $125,000
  • Robert Roth, Organon Laboratories Ltd., Influence of Asenapine on Dopamine and Serotonin Turnover in the Phencyclidine Model of Frontal Cortical Dysfunction in Non-Human Primates, 2 years, $68,670
  • David Rothstein, University of California–San Diego, Endotoxin and Allergy: Modulation by CTLA4, 17 months, $8,226
  • Joseph Schlessinger, Ludwig Institute for Cancer Research, Coupling Between FGF and Signaling via TGF Receptors, 1 year, $75,000
  • Robert Schultz, Vanderbilt University, Perpetual Expertise Network: Dynamics of Object Perception, 1 year, $46,325
  • Hong Wang, Harvard University, Social Experimental Study on RMHC Community-Based Health Insurance in Rural China, 3 years, $86,237
  • Carol Weitzman, The Children’s Fund of Connecticut, Behavioral Health of Young Children in Primary Care Settings, 2 years, $178,561
  • Dagan Wells, ART Institute of New York and New Jersey, Analysis of Cell-Cycle Checkpoints in Human Oocytes, 15 months, $16,792
  • Herbert Yu, American Association for Cancer Research, Methylator Phenotype of Insulin-Like Growth Factors in Breast Cancer, 2 years, $160,000
Jump to top.

Jump to top.

Copyright 2006, Yale University School of Medicine. All rights reserved. Email comments or suggestions to: editor@info.med.yale.edu